According to Adaptive Biotechnologies 's latest financial reports the company's current revenue (TTM) is $0.17 B. In 2022 the company made a revenue of $0.18 B an increase over the years 2021 revenue that were of $0.15 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.17 B | -8.11% |
2022 | $0.18 B | 20.06% |
2021 | $0.15 B | 56.88% |
2020 | $98.38 M | 15.65% |
2019 | $85.07 M | 52.83% |
2018 | $55.66 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
HCA Healthcare HCA | $64.96 B | 38,054.53% | ๐บ๐ธ USA |
Premier PINC | $1.31 B | 672.92% | ๐บ๐ธ USA |
Community Health Systems
CYH | $12.49 B | 7,235.74% | ๐บ๐ธ USA |
Select Medical Holdings SEM | $6.66 B | 3,813.68% | ๐บ๐ธ USA |